Spain: AEMPS gives MedTech companies another 11 months to adapt to Brexit

By Published On: May 29th, 20200.9 min read

Spain: AEMPS gives MedTech companies another 11 months to adapt to Brexit

By Published On: May 29th, 20200.9 min read

The Spanish Agency of Medicines and Medical Devices (AEMPS) moved to May 25th, 2021 the deadline for changing the labelling and instructions for use of medical devices due to Brexit.

This decision aims at  allowing manufacturers to face the challenges imposed by the COVID-19 emergency.

For more details, please see:

Meditrial can help – Contact us for immediate support

Meditrial has developed rapid workflows to conduct risk assessment, implement rescue plans and execute solutions for ongoing clinical trials:

Contact Meditrial for immediate assistance in Europe or the US.

Table of Contents

Latest Articles

This article provides general information and does not constitute regulatory, legal, clinical, or compliance advice. Requirements and appropriate processes may vary by study, product, jurisdiction, and organization. Medigen Suite functionality should be used in accordance with applicable regulations, study documentation, and internal procedures.

Go to Top